| Nome |
# |
|
Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis., file e4233f14-ed43-2860-e053-6605fe0a460a
|
513
|
|
Critical review on biofilm methods, file e4233f16-e0e7-2860-e053-6605fe0a460a
|
265
|
|
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions, file e4233f17-8a31-2860-e053-6605fe0a460a
|
208
|
|
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus, file e4233f15-a4d3-2860-e053-6605fe0a460a
|
174
|
|
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance, file e4233f17-71ae-2860-e053-6605fe0a460a
|
115
|
|
In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis, file e4233f18-76e4-2860-e053-6605fe0a460a
|
77
|
|
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections, file e4233f15-9e04-2860-e053-6605fe0a460a
|
66
|
|
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature, file e4233f15-d074-2860-e053-6605fe0a460a
|
59
|
|
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains, file e4233f19-6d52-2860-e053-6605fe0a460a
|
51
|
|
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm, file e4233f15-43cc-2860-e053-6605fe0a460a
|
39
|
|
Editorial: A Multidisciplinary Look at Stenotrophomonas maltophilia: An Emerging Multi-Drug-Resistant Global Opportunistic Pathogen., file e4233f16-e0e6-2860-e053-6605fe0a460a
|
33
|
|
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient, file e4233f15-a4d2-2860-e053-6605fe0a460a
|
29
|
|
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection, file e4233f16-e0e5-2860-e053-6605fe0a460a
|
29
|
|
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus, file e4233f15-d4de-2860-e053-6605fe0a460a
|
22
|
|
null, file e4233f17-9366-2860-e053-6605fe0a460a
|
21
|
|
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study, file e4233f16-906f-2860-e053-6605fe0a460a
|
20
|
|
Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients, file e4233f17-a195-2860-e053-6605fe0a460a
|
18
|
|
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector, file e4233f18-fb94-2860-e053-6605fe0a460a
|
18
|
|
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients., file e4233f15-02d9-2860-e053-6605fe0a460a
|
17
|
|
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide, file e4233f17-eb15-2860-e053-6605fe0a460a
|
17
|
|
Normal breathing releases SARS-CoV-2 into the air, file e4233f18-76d4-2860-e053-6605fe0a460a
|
17
|
|
Microbiological Laboratory Diagnosis of Human Brucellosis: An Overview, file e4233f19-13b1-2860-e053-6605fe0a460a
|
17
|
|
Electrochemically Synthesized Silver Nanoparticles Are Active Against Planktonic and Biofilm Cells of Pseudomonas aeruginosa and Other Cystic Fibrosis-Associated Bacterial Pathogens, file 6b4b2f0b-926d-42fc-9c5b-26fd997c8067
|
16
|
|
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model., file e4233f16-905a-2860-e053-6605fe0a460a
|
16
|
|
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis., file e4233f16-f115-2860-e053-6605fe0a460a
|
16
|
|
Growth control of adherent-invasive Escherichia coli (AIEC) by the predator bacteria Bdellovibrio bacteriovorus: a new therapeutic approach for Crohn’s disease patients, file e4233f17-9412-2860-e053-6605fe0a460a
|
16
|
|
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector, file e4233f15-81bf-2860-e053-6605fe0a460a
|
15
|
|
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies, file e4233f17-77d3-2860-e053-6605fe0a460a
|
14
|
|
Olive Pâté by Multi-Phase Decanter as Potential Source of Bioactive Compounds of Both Nutraceutical and Anticancer Effects, file e4233f18-3ffc-2860-e053-6605fe0a460a
|
11
|
|
Electrochemically synthesized silver nanoparticles are active against planktonic and biofilm cells of Pseudomonas aeruginosa and other cystic fibrosis-associated bacterial pathogens, file e4233f18-fd6c-2860-e053-6605fe0a460a
|
11
|
|
Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms?, file e4233f19-3283-2860-e053-6605fe0a460a
|
10
|
|
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods, file e4233f14-ed3f-2860-e053-6605fe0a460a
|
9
|
|
Repurposing the Veterinary Antibiotic Apramycin for Antibacterial and Antibiofilm Activity Against Pseudomonas aeruginosa From Cystic Fibrosis Patients, file e4233f19-3282-2860-e053-6605fe0a460a
|
9
|
|
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia., file e4233f16-ea01-2860-e053-6605fe0a460a
|
8
|
|
A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study)., file e4233f17-04e0-2860-e053-6605fe0a460a
|
8
|
|
Gram-Negative Bacteria Holding Together in a Biofilm: The Acinetobacter baumannii Way, file e4233f19-13af-2860-e053-6605fe0a460a
|
8
|
|
Laboratory and clinical comparison of preservation media and transport conditions for survival of Actunobacillus actinomycetemcomitans, file 4ee1ccd1-9803-4305-998f-16c0b10ca77e
|
7
|
|
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis, file ca65a208-9e80-4c05-8d9d-0ff98f3a7875
|
7
|
|
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ?, file e4233f14-eb82-2860-e053-6605fe0a460a
|
7
|
|
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions, file e4233f15-a40f-2860-e053-6605fe0a460a
|
7
|
|
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis, file e4233f16-d6f0-2860-e053-6605fe0a460a
|
7
|
|
Biofilm formation under food-relevant conditions and sanitizers' tolerance of a Pseudomonas fluorescens group strain, file 5c32f35b-21f4-43cb-ad1c-6bb002a5aea2
|
6
|
|
Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains, file b29efccf-438b-4e07-8b0e-06b822457b43
|
6
|
|
Comparative Proteomic Analysis of Protein Patterns of Stenotrophomonas maltophilia in Biofilm and Planktonic Lifestyles, file e949526d-0f89-4e69-84b7-331dffa491b3
|
5
|
|
Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis, file c6e713b8-c0f8-4ee8-a8d1-5c9f24c4983e
|
4
|
|
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis., file e4233f17-83b9-2860-e053-6605fe0a460a
|
3
|
|
Cell-free supernatants from Lactobacillus strains exert antibacterial, antibiofilm, and antivirulence activity against Pseudomonas aeruginosa from cystic fibrosis patients, file a4b34704-436a-4e59-80f4-bebd119ca853
|
2
|
|
Influence of temperature on biofilm formation by Listeria monocytogenes on various food-contact surfaces: relationship with motility and cell surface hydrophobicity., file e4233f14-f8ab-2860-e053-6605fe0a460a
|
2
|
|
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression, file e4233f15-d179-2860-e053-6605fe0a460a
|
2
|
|
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS, file e4233f16-3609-2860-e053-6605fe0a460a
|
2
|
|
A case ofpharyngitis caused by Streptococcus pneumoniae., file e4233f17-7b2c-2860-e053-6605fe0a460a
|
2
|
|
Colonic adenoma-associated Escherichia coli express specific phenotypes, file e4233f17-84e5-2860-e053-6605fe0a460a
|
2
|
|
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product, file e4233f18-bede-2860-e053-6605fe0a460a
|
2
|
|
In Vitro Antimicrobial Susceptibility Testing of Biofilm-Growing Bacteria: Current and Emerging Methods, file e4233f19-13ad-2860-e053-6605fe0a460a
|
2
|
|
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis., file e4233f14-ee06-2860-e053-6605fe0a460a
|
1
|
|
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime., file e4233f14-ee3b-2860-e053-6605fe0a460a
|
1
|
|
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients., file e4233f14-eea4-2860-e053-6605fe0a460a
|
1
|
|
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection., file e4233f14-ef72-2860-e053-6605fe0a460a
|
1
|
|
In vitro microbiology studies on a new peritoneal dialysis connector, file e4233f14-f81b-2860-e053-6605fe0a460a
|
1
|
|
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments., file e4233f14-fd0e-2860-e053-6605fe0a460a
|
1
|
|
Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients., file e4233f15-4a52-2860-e053-6605fe0a460a
|
1
|
|
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens, file e4233f15-4b15-2860-e053-6605fe0a460a
|
1
|
|
Unusual oropharyngeal asymptomatic manifestations caused by atypical pathogens detected by PCR into altered ecosystems of an infertile couple., file e4233f15-69c1-2860-e053-6605fe0a460a
|
1
|
|
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients, file e4233f17-80ef-2860-e053-6605fe0a460a
|
1
|
|
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients, file e4233f18-b433-2860-e053-6605fe0a460a
|
1
|
| Totale |
2.078 |